- Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
22-May-2019 Interstitial Lung Disease (ILD) Experts And Advocates Announce Formation Of Open Source Imaging Consortium (OSIC) Open Source Imaging Consortium (OSIC)
22-May-2019 Alkermes to Present New Data From Mental Health Portfolio at the American Society of Clinical Psychopharmacology 2019 Annual Meeting Alkermes plc
22-May-2019 Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement Halozyme Therapeutics, Inc.
21-May-2019 Mallinckrodt Announces Election of Carlos V. Paya, M.D., Ph.D. to its Board of Directors Mallinckrodt plc
21-May-2019 Lilly's Mirikizumab Met Primary Endpoint and Key Secondary Endpoints in Phase 2 Study, Including Reductions of Gastrointestinal Lesions Eli Lilly & Company
21-May-2019 Noridian Posts Favorable Draft Local Coverage Determination for Natera's Prospera(TM) Kidney Transplant Test Natera
21-May-2019 PolyPid Receives a Second QIDP Designation for D-PLEX100 in Abdominal Surgery Polypid Ltd.
21-May-2019 UKI2S and Innovate UK launch new £10m initiative to accelerate growth of early stage science and engineering companies UKI2S
21-May-2019 Oncopeptides AB: INTERIM REPORT Q1 2019 Oncopeptides AB
20-May-2019 Insmed Announces Proposed Public Offering of Common Stock Insmed Incorporated
20-May-2019 Catalent Completes Acquisition Of Gene Therapy Leader Paragon Bioservices, Inc. For $1.2 Billion Catalent
20-May-2019 Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss Rinri Therapeutics
20-May-2019 Promedior Announces Positive Long-term Safety and Efficacy Data from Open Label Extension Study of PRM-151 in Idiopathic Pulmonary Fibrosis Promedior
20-May-2019 Biocept Announces Clinical Validation and Commercial Launch of its Target Selector(TM) Multi-Gene Liquid Biopsy Panel for Lung Cancer Biocept, Inc.
20-May-2019 Reneo Pharmaceuticals Raises $50 Million to Develop Therapeutics to Treat Genetic Mitochondrial Diseases Reneo Pharmaceuticals
20-May-2019 Astellas Oncology Announces C³ Prize® Call for Entries to Award $200,000 to the Best Ideas in Cancer Care Beyond Medicine Astellas Pharma US, Inc.
20-May-2019 Cellular Biomedicine Group to Present at B. Riley FBR Annual Investor Conference Cellular Biomedicine Group
20-May-2019 PTC Therapeutics Announces First-Ever Winners of Its PRIORITY Program To Support Research Projects In Rare, Genetic Disorders PTC Therapeutics, Inc.
20-May-2019 Respivant Sciences Announces Dosing of First Patient in Phase 2b Trial of RVT-1601 for the Treatment of Persistent Cough Due to Idiopathic Pulmonary Fibrosis Respivant Sciences
20-May-2019 Strata Oncology to Present Interim Data from the Strata Trial at the 2019 American Society of Clinical Oncology Annual Meeting Strata Oncology, Inc.